Legis Daily

CURE High Drug Prices Act

USA116th CongressS-637| Senate 
| Updated: 2/28/2019
Richard Blumenthal

Richard Blumenthal

Democratic Senator

Connecticut

Cosponsors (5)
Kamala D. Harris (Democratic)Amy Klobuchar (Democratic)Bernard Sanders (Independent)Brian Schatz (Democratic)Jeff Merkley (Democratic)

Health, Education, Labor, and Pensions Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Combatting Unreasonable Rises and Excessively High Drug Prices Act or the CURE High Drug Prices Act This bill prohibits price gouging by manufacturers of prescription drugs (including a combination of a drug, device, or biological product) that are covered by a federal health care program. The bill specifies percentage increases in price at which price gouging is presumed.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Feb 28, 2019
Introduced in Senate
Feb 28, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Aug 5, 2019

Latest Companion Bill Action

HR 116-4158
Referred to the Subcommittee on Health.
  • February 28, 2019
    Introduced in Senate
  • February 28, 2019
    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  • August 5, 2019

    Latest Companion Bill Action

    HR 116-4158
    Referred to the Subcommittee on Health.

Health

Related Bills

  • HR 116-4158: CURE High Drug Prices Act
Administrative remediesCivil actions and liabilityHealth care costs and insuranceHealth care coverage and accessHealth programs administration and fundingInflation and pricesPrescription drugs

CURE High Drug Prices Act

USA116th CongressS-637| Senate 
| Updated: 2/28/2019
Combatting Unreasonable Rises and Excessively High Drug Prices Act or the CURE High Drug Prices Act This bill prohibits price gouging by manufacturers of prescription drugs (including a combination of a drug, device, or biological product) that are covered by a federal health care program. The bill specifies percentage increases in price at which price gouging is presumed.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Feb 28, 2019
Introduced in Senate
Feb 28, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Aug 5, 2019

Latest Companion Bill Action

HR 116-4158
Referred to the Subcommittee on Health.
  • February 28, 2019
    Introduced in Senate
  • February 28, 2019
    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  • August 5, 2019

    Latest Companion Bill Action

    HR 116-4158
    Referred to the Subcommittee on Health.
Richard Blumenthal

Richard Blumenthal

Democratic Senator

Connecticut

Cosponsors (5)
Kamala D. Harris (Democratic)Amy Klobuchar (Democratic)Bernard Sanders (Independent)Brian Schatz (Democratic)Jeff Merkley (Democratic)

Health, Education, Labor, and Pensions Committee

Health

Related Bills

  • HR 116-4158: CURE High Drug Prices Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Administrative remediesCivil actions and liabilityHealth care costs and insuranceHealth care coverage and accessHealth programs administration and fundingInflation and pricesPrescription drugs